Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Recurrent or Refractory Multiple Myeloma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Large-scale testing (Phase 3)Study completedNCT00004230
What this trial is testing

Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation

Who this might be right for
Cancer
Northwestern University 35
Early research (Phase 1)Ended earlyNCT04214093
What this trial is testing

AZD0466 in Patients With Advanced Hematologic or Solid Tumors

Who this might be right for
Advanced Solid TumorsLymphomaMultiple Myeloma+1 more
AstraZeneca 9
Large-scale testing (Phase 3)UnknownNCT00002989
What this trial is testing

Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
European Organisation for Research and Treatment of Cancer - EORTC 207
Early research (Phase 1)Study completedNCT01371227
What this trial is testing

JNS002 (Doxorubicin Hydrochloride Liposome Injection) in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Pharmaceutical K.K. 3
Early research (Phase 1)Active Not RecruitingNCT03798678
What this trial is testing

CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma

Who this might be right for
Recurrent Multiple MyelomaRefractory Multiple Myeloma
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT00237627
What this trial is testing

Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer

Who this might be right for
Breast CancerLeukemiaLymphoma+3 more
UNC Lineberger Comprehensive Cancer Center 107
Early research (Phase 1)Study completedNCT00991562
What this trial is testing

IMGN901 in Combination With Lenalidomide and Dexamethasone

Who this might be right for
Multiple Myeloma
ImmunoGen, Inc. 50
Testing effectiveness (Phase 2)Ended earlyNCT03333746
What this trial is testing

Lenalidomide and Nivolumab in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Yvonne Efebera 1
Early research (Phase 1)UnknownNCT03711864
What this trial is testing

Safety and Efficacy of IM21 Car-t Cells in Patients With Recurrent or Refractory BCMA Positive Multiple Myeloma

Who this might be right for
Multiple Myeloma
Peking Union Medical College Hospital 15
Early research (Phase 1)Temporarily pausedNCT03710421
What this trial is testing

CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory CS1 Positive Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
City of Hope Medical Center 30
Early research (Phase 1)Study completedNCT02095834
What this trial is testing

Carfilzomib, Bendamustine Hydrochloride, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
M.D. Anderson Cancer Center 18
Early research (Phase 1)Study completedNCT00513474
What this trial is testing

Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Massachusetts General Hospital 46
Early research (Phase 1)Study completedNCT02514382
What this trial is testing

Wild-Type Reovirus, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
University of Southern California 14
Early research (Phase 1)Ended earlyNCT02109224
What this trial is testing

Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection

Who this might be right for
Adult B Acute Lymphoblastic LeukemiaChronic Lymphocytic LeukemiaCutaneous B-Cell Non-Hodgkin Lymphoma+26 more
National Cancer Institute (NCI) 72
Testing effectiveness (Phase 2)Ended earlyNCT01946152
What this trial is testing

Pomalidomide, Dexamethasone, and Filgrastim-sndz in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma-Light Chain OnlyRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT03763162
What this trial is testing

Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
M.D. Anderson Cancer Center 40
Not applicableEnded earlyNCT00946283
What this trial is testing

Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersLeukemia+7 more
Rutgers, The State University of New Jersey 30
Testing effectiveness (Phase 2)Looking for participantsNCT06484829
What this trial is testing

Purinostat Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma (RRMM)
Chengdu Zenitar Biomedical Technology Co., Ltd 144
Testing effectiveness (Phase 2)Study completedNCT01326702
What this trial is testing

Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory Lymphoma, Multiple Myeloma, or Solid Tumors

Who this might be right for
Adult B Acute Lymphoblastic LeukemiaAdult Nasal Type Extranodal NK/T-Cell LymphomaAdult Solid Neoplasm+35 more
National Cancer Institute (NCI) 43
Next Page